Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ehlers-Danlos Syndrome, Type IV MeSH Descriptor Data 2025


MeSH Heading
Ehlers-Danlos Syndrome, Type IV
Tree Number(s)
C14.907.055.448.250.256
C14.907.454.240.500
C15.378.463.515.240.500
C16.131.831.428.500
C16.320.850.260.500
C17.300.200.310.500
C17.800.804.428.500
C17.800.827.260.500
Unique ID
D000094623
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000094623
Scope Note
A subtype of Ehlers-Danlos syndrome (EDS) characterized by vascular pathologies, e.g., AORTIC DISSECTION in addition to common EDS findings, e.g., hyperextensible skin and joints, skin fragility and reduced wound healing capability. It is associated with mutations in collagen type III alpha 1 chain gene (COLLAGEN TYPE III).
Entry Term(s)
EDS IV
Ehlers Danlos Syndrome Type 4, Autosomal Dominant
Ehlers Danlos Syndrome, Arterial Type
Ehlers Danlos Syndrome, Ecchymotic Type
Ehlers Danlos Syndrome, Sack-Barabas Type
Ehlers-Danlos Syndrome, Arterial Type
Ehlers-Danlos Syndrome, Ecchymotic Type
Ehlers-Danlos Syndrome, Sack-Barabas Type
Ehlers-Danlos Syndrome, Type IV, Autosomal Dominant
Ehlers-Danlos Syndrome, Vascular Type
Type IV Ehlers-Danlos Syndrome
Vascular Ehlers-Danlos Syndrome
Vascular Type Ehlers-Danlos Syndrome
Public MeSH Note
2023; use EHLERS-DANLOS SYNDROME 2008-2022
History Note
2023; see EHLERS-DANLOS SYNDROME 2008-2022
Date Established
2023/01/01
Date of Entry
2022/07/08
Revision Date
2022/05/23
Ehlers-Danlos Syndrome, Type IV Preferred
page delivered in 0.131s